Scott David Collins has a solid background in Pharmacology, with experience in companies such as Mersana Therapeutics, Novartis Institutes for BioMedical Research, and AstraZeneca. Currently serving as the Director of Non-Clinical Development at Mersana Therapeutics, Scott David Collins has held various roles in Pharmacology and Toxicology Biology throughout their career. Additionally, Scott David has experience in the academic sector as a Student Ambassador at the University of Manchester.
October, 2022 - present
July, 2020
January, 2018